Hoey Investments Inc. Has $188,000 Position in Danaher Co. (NYSE:DHR)

Hoey Investments Inc. cut its stake in Danaher Co. (NYSE:DHR) by 37.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 821 shares of the conglomerate’s stock after selling 487 shares during the period. Hoey Investments Inc.’s holdings in Danaher were worth $188,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the stock. Axiom Investors LLC DE grew its stake in Danaher by 24.3% during the fourth quarter. Axiom Investors LLC DE now owns 716,576 shares of the conglomerate’s stock worth $164,490,000 after buying an additional 140,191 shares in the last quarter. Partners in Financial Planning acquired a new stake in shares of Danaher during the 4th quarter worth approximately $433,000. Prevail Innovative Wealth Advisors LLC acquired a new position in Danaher during the fourth quarter valued at approximately $3,768,000. Physician Wealth Advisors Inc. bought a new stake in Danaher during the fourth quarter worth $82,000. Finally, RWA Wealth Partners LLC boosted its holdings in shares of Danaher by 8.1% in the 4th quarter. RWA Wealth Partners LLC now owns 12,856 shares of the conglomerate’s stock valued at $2,951,000 after purchasing an additional 960 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 11.10% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently commented on DHR. Guggenheim initiated coverage on Danaher in a report on Thursday, December 19th. They set a “buy” rating and a $275.00 price target for the company. JPMorgan Chase & Co. dropped their target price on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. StockNews.com lowered shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. Bank of America upgraded shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price on the stock in a research report on Friday, December 13th. Finally, Scotiabank started coverage on Danaher in a research note on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price target for the company. Five equities research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company’s stock. According to MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and an average price target of $278.24.

Danaher Price Performance

Shares of NYSE DHR opened at $205.69 on Monday. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The company has a market capitalization of $147.01 billion, a PE ratio of 38.96, a P/E/G ratio of 2.66 and a beta of 0.82. The firm has a fifty day simple moving average of $214.57 and a 200 day simple moving average of $236.39. Danaher Co. has a twelve month low of $196.80 and a twelve month high of $281.70.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period last year, the firm posted $2.09 earnings per share. On average, sell-side analysts forecast that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.62%. This is a boost from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date is Friday, March 28th. Danaher’s dividend payout ratio is presently 24.24%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.